DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Angina Pectoris Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2012 to 2022" report to their offering.
This new market research reports includes market figures, market size and estimations for applications and products depending upon geographical location for the forecast period to 2022. Further, the study also encompasses complete industry background, drivers, restraints, growth opportunities, challenges and critical success factors (CSFs).
The report examines top industry competitors, offering organization market share analysis and detailed outlines of these firms, with product bench-marking.
Reasons to Purchase:
- Explore global Angina Pectoris Treatment Market growth rate, market size and projection to 2022 and drivers of global Angina Pectoris Treatment Market
- Key Challenges
- Major prospects in the Angina Pectoris Treatment Market
- In-Depth regional evaluations by application ( Europe, North America APAC and Rest of the World) of global Angina Pectoris Treatment Market business
Competitive background, with Angina Pectoris Treatment Market firm
market share and detailed overviews/ summaries of major
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Angina Pectoris Treatment Market: Market Dynamics and Outlook
Chapter 4 Global Angina Pectoris Treatment Market, By Drug Class
Chapter 5 Global Angina Pectoris Treatment Market, By Geography
Chapter 6 Company Profiles
- Abbott Laboratories Inc.
- Astra Zeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche Ltd.
- Forest Laboratories Inc.
- Gilead Sciences, Inc.
- GlaxoSmithKline plc
- Novartis AG
- Pfizer Inc.
For more information visit http://www.researchandmarkets.com/research/j8xbsp/global_angina